These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 766879)

  • 21. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccination against rubella of susceptible schoolgirls in Reading.
    Rowlands DF; Freestone DS
    J Hyg (Lond); 1971 Dec; 69(4):579-86. PubMed ID: 4257464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 33. [Seroimmunity against rubella 5 years after immunisation with Cendehill vaccine (author's transl)].
    Sarateanu DE; Ehrengut W
    Immun Infekt; 1975 Apr; 3(2):51-3. PubMed ID: 1184096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Directed immunization of female employees in the health services and schools using live rubella vaccine strain RA 27/3 on the basis of a screening test with radial hemolysis].
    Strauss J; Mrázová M; Macátová I; Růzicka E
    Cesk Epidemiol Mikrobiol Imunol; 1987 Oct; 36(5):271-9. PubMed ID: 2959379
    [No Abstract]   [Full Text] [Related]  

  • 35. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
    Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
    Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines.
    Wallace RB; Isacson P
    Am J Dis Child; 1972 Oct; 124(4):536-8. PubMed ID: 4562789
    [No Abstract]   [Full Text] [Related]  

  • 37. Rubella immunization. Persistence of antibody four years after a large-scale field trial.
    Herrmann KL; Halstead SB; Brandling-Bennett AD; Witte JJ; Wiebenga NH; Eddins DL
    JAMA; 1976 May; 235(20):2201-4. PubMed ID: 946844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose response studies with Wistar RA 27/3 strain live attenuated rubella vaccine.
    Zealley H; Morrison AM; Freestone DS
    J Biol Stand; 1974 Apr; 2(2):111-9. PubMed ID: 4459391
    [No Abstract]   [Full Text] [Related]  

  • 39. Rubella antibody persistence after immunization.
    Herrmann KL; Halstead SB; Wiebenga NH
    JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine.
    Hillary IB; Griffith AH
    Vaccine; 1984 Dec; 2(4):274-6. PubMed ID: 6531967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.